Mead Johnson Nutrition Director Sells $777,800 in Stock (MJN)
Mead Johnson Nutrition (NYSE:MJN) Director Stephen W. Golsby unloaded 10,000 shares of Mead Johnson Nutrition stock in a transaction that occurred on Friday, February 14th. The stock was sold at an average price of $77.78, for a total value of $777,800.00. Following the transaction, the director now directly owns 80,920 shares of the company’s stock, valued at approximately $6,293,958. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link.
Shares of Mead Johnson Nutrition (NYSE:MJN) traded down 0.10% during mid-day trading on Friday, hitting $78.04. The stock had a trading volume of 355,705 shares. Mead Johnson Nutrition has a one year low of $66.80 and a one year high of $86.87. The stock has a 50-day moving average of $80.78 and a 200-day moving average of $79.39. The company has a market cap of $15.731 billion and a price-to-earnings ratio of 24.49.
Mead Johnson Nutrition (NYSE:MJN) last released its earnings data on Friday, January 31st. The company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.01. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the previous year, the company posted $0.72 earnings per share. The company’s revenue for the quarter was up 8.0% on a year-over-year basis. Analysts expect that Mead Johnson Nutrition will post $3.62 EPS for the current fiscal year.
A number of analysts have recently weighed in on MJN shares. Analysts at Wells Fargo & Co. upgraded shares of Mead Johnson Nutrition from a “market perform” rating to an “outperform” rating in a research note on Monday. Separately, analysts at Socgen initiated coverage on shares of Mead Johnson Nutrition in a research note on Friday, January 31st. They set a “buy” rating on the stock. Finally, analysts at Societe Generale initiated coverage on shares of Mead Johnson Nutrition in a research note on Thursday, January 30th. They set a “buy” rating on the stock. Seven research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has assigned a strong buy rating to the company. Mead Johnson Nutrition currently has an average rating of “Buy” and a consensus target price of $86.73.
Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.